HepaTx Corporation is developing regenerative medicine solutions to address the need for better therapies for life-threatening liver diseases.  Our technology invented at Stanford University enables efficient hepatocyte production for therapeutic purposes.  Our therapeutics can replace lost liver function to treat those with end-stage of liver disease, potentially saving the cost and morbidity of whole organ transplant. Hepatx is located in Palo Alto, CA, in the heart of Silicon Valley.